ATE285795T1 - Polypropylenbasierte behälter für prostaglandin- enthaltende produkte - Google Patents

Polypropylenbasierte behälter für prostaglandin- enthaltende produkte

Info

Publication number
ATE285795T1
ATE285795T1 AT99931790T AT99931790T ATE285795T1 AT E285795 T1 ATE285795 T1 AT E285795T1 AT 99931790 T AT99931790 T AT 99931790T AT 99931790 T AT99931790 T AT 99931790T AT E285795 T1 ATE285795 T1 AT E285795T1
Authority
AT
Austria
Prior art keywords
containing products
polypropylene based
based containers
prostaglandin containing
prostaglandin
Prior art date
Application number
AT99931790T
Other languages
English (en)
Inventor
Alan L Weiner
Subhash C Airy
Cody Yarborough
Julia A Clifford
William E Mccune
Original Assignee
Alcon Mfg Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22235155&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE285795(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alcon Mfg Ltd filed Critical Alcon Mfg Ltd
Application granted granted Critical
Publication of ATE285795T1 publication Critical patent/ATE285795T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
AT99931790T 1998-07-14 1999-06-15 Polypropylenbasierte behälter für prostaglandin- enthaltende produkte ATE285795T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9278698P 1998-07-14 1998-07-14
PCT/US1999/013276 WO2000003736A1 (en) 1998-07-14 1999-06-15 Prostaglandin product

Publications (1)

Publication Number Publication Date
ATE285795T1 true ATE285795T1 (de) 2005-01-15

Family

ID=22235155

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99931790T ATE285795T1 (de) 1998-07-14 1999-06-15 Polypropylenbasierte behälter für prostaglandin- enthaltende produkte

Country Status (15)

Country Link
EP (1) EP1011728B1 (de)
JP (2) JP2002520368A (de)
KR (1) KR20010021835A (de)
CN (1) CN1146423C (de)
AR (1) AR019773A1 (de)
AT (1) ATE285795T1 (de)
AU (1) AU743607B2 (de)
BR (1) BR9906597A (de)
CA (1) CA2295512C (de)
DE (1) DE69922916T2 (de)
ES (1) ES2234270T3 (de)
PT (1) PT1011728E (de)
TW (1) TW585769B (de)
WO (1) WO2000003736A1 (de)
ZA (1) ZA997794B (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2295512C (en) * 1998-07-14 2009-05-26 Alcon Laboratories, Inc. Prostaglandin product
CA2364948C (en) 1999-03-05 2011-04-26 Duke University C16 unsaturated fp-selective prostaglandins analogs
US6894175B1 (en) 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
ES2337981T3 (es) * 1999-09-10 2010-05-03 Taisho Pharmaceutical Co., Ltd Derivados de prostaglandina.
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
PT1321144E (pt) * 2000-09-13 2011-03-10 Santen Pharmaceutical Co Ltd Colírio
WO2002022106A2 (en) * 2000-09-14 2002-03-21 Novartis Ag Stable ophthalmic preparation
CA2477418A1 (en) 2002-03-18 2003-09-25 Santen Pharmaceutical Co., Ltd. High-temperature-sterilizable instillator
EP1532981B1 (de) * 2002-08-23 2007-09-26 Santen Pharmaceutical Co., Ltd. Stabile augentropfen enthaltend latanoprost als wirkstoff
US20060199863A1 (en) * 2003-07-31 2006-09-07 Santen Pharmaceutical Co., Ltd. Product containing prostaglandin
CA2590277C (en) * 2004-12-09 2014-07-08 Santen Pharmaceutical Co., Ltd. Product containing prostaglandin having fluorine atom in its molecule
JP4753178B2 (ja) * 2004-12-24 2011-08-24 参天製薬株式会社 プロスタグランジンＦ２α誘導体含有製品
DK1829545T3 (da) * 2004-12-24 2012-07-23 Santen Pharmaceutical Co Ltd Produkter indeholdende prostaglandin-F2alfa-derivat
US8030349B2 (en) * 2005-08-02 2011-10-04 Santen Pharmaceutical Co., Ltd. Method for prevention of degradation of thermally unstable medicament
JP5252787B2 (ja) * 2005-08-02 2013-07-31 参天製薬株式会社 熱的に不安定な薬物の分解抑制方法
WO2007105691A1 (ja) * 2006-03-13 2007-09-20 R-Tech Ueno, Ltd. 水性組成物
CN105566192B (zh) * 2006-10-02 2019-01-22 于崇曦 具有快速皮肤穿透速度的带正电荷的水溶性的前列腺素及相关化合物的前药
US8455513B2 (en) 2007-01-10 2013-06-04 Aerie Pharmaceuticals, Inc. 6-aminoisoquinoline compounds
EP2123278B1 (de) * 2007-02-07 2013-01-09 Teika Pharmaceutical Co., Ltd. Augentropfenzubereitung mit latanoprost
JP5327809B2 (ja) * 2007-08-29 2013-10-30 わかもと製薬株式会社 ラタノプロスト含有水性医薬組成物
MX2010004211A (es) * 2007-10-16 2010-06-30 Sun Pharma Advanced Res Co Ltd Composicion oftalmica que comprende una prostaglandina.
TWI544927B (zh) * 2008-03-17 2016-08-11 愛爾康研究有限公司 具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物
JP2009256281A (ja) * 2008-04-21 2009-11-05 Teika Seiyaku Kk イソプロピルウノプロストン含有点眼剤組成物
EP2127638A1 (de) * 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Verfahren und Zusammensetzung zur Behandlung von Augenhochdruck und Glaukom
US8450344B2 (en) 2008-07-25 2013-05-28 Aerie Pharmaceuticals, Inc. Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
US20100087540A1 (en) * 2008-10-07 2010-04-08 R-Tech Ueno, Ltd. Pharmaceutical composition
RU2482851C2 (ru) * 2009-02-20 2013-05-27 Микро Лабс Лимитед Хранение стабильного продукта простагландина
WO2010126626A2 (en) 2009-05-01 2010-11-04 Aerie Pharmaceuticals, Inc. Dual mechanism inhibitors for the treatment of disease
DE102009021372A1 (de) * 2009-05-14 2010-11-18 Ursapharm Arzneimittel Gmbh Phosphatfreie pharmazeutische Zusammensetzung zur Glaukombehandlung
US20120232139A1 (en) * 2009-09-01 2012-09-13 Ryuji Ueno Composition for ocular topical administration treatment ocular hypertension and glaucoma
CA2773597A1 (en) 2009-09-17 2011-03-24 Senju Pharmaceutical Co., Ltd. Latanoprost-containing aqueous eye drops and method for inhibiting adsorption of latanoprost to resin
WO2012051116A1 (en) * 2010-10-12 2012-04-19 The Medicines Company Clevidipine emulsion formulations containing antimicrobial agents
US8658676B2 (en) 2010-10-12 2014-02-25 The Medicines Company Clevidipine emulsion formulations containing antimicrobial agents
EP2452669A1 (de) 2010-10-29 2012-05-16 Omnivision GmbH Ophthalmische Zusammensetzung
EP2567689A1 (de) 2011-09-12 2013-03-13 Visiotact Pharma Ophthalmische Zusammensetzungen enhaltend Prostaglandin-F2-alpha-Derivate und Hyaluronsäure
ES2776199T3 (es) 2013-03-15 2020-07-29 Aerie Pharmaceuticals Inc Conjugados de compuestos de isoquinolina y prostaglandinas
MX385505B (es) 2014-01-10 2025-03-18 Santen Pharmaceutical Co Ltd Composicion farmaceutica que contiene compuesto de acido piridilaminoacetico
KR102111157B1 (ko) * 2014-01-10 2020-05-14 산텐 세이야꾸 가부시키가이샤 피리딜아미노아세트산 화합물과 폴리옥시에틸렌 피마자유를 함유하는 의약 조성물
CA2970254A1 (en) * 2014-12-12 2016-06-16 Kowa Company, Ltd. Composition
US9643927B1 (en) 2015-11-17 2017-05-09 Aerie Pharmaceuticals, Inc. Process for the preparation of kinase inhibitors and intermediates thereof
WO2018045091A1 (en) 2016-08-31 2018-03-08 Aerie Pharmaceuticals, Inc. Ophthalmic compositions
CA3057872A1 (en) 2017-03-31 2018-10-04 Aerie Pharmaceuticals, Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds
AU2019337703B2 (en) 2018-09-14 2023-02-02 Aerie Pharmaceuticals, Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds
KR102756146B1 (ko) * 2019-06-28 2025-01-17 한미약품 주식회사 저장 안정성이 개선된 라타노프로스트 함유 점안제

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0242580B1 (de) * 1986-03-13 1993-04-28 The Trustees Of Columbia University In The City Of New York Verwendung von A-, B- und C-Prostaglandinen und deren Derivaten zur Behandlung von Augen-Hypertension und Glaukom
JPS62292719A (ja) * 1986-06-12 1987-12-19 Kaken Pharmaceut Co Ltd 外用澄明水溶性製剤
ZA88963B (en) * 1987-02-27 1989-11-29 Allergan Inc Prostaglandins useful for lowering intraocular pressure
JPH0228112A (ja) * 1988-04-21 1990-01-30 Kaken Pharmaceut Co Ltd 点眼用眼圧調整剤
JP3256997B2 (ja) * 1990-08-30 2002-02-18 千寿製薬株式会社 安定な水性製剤
US5425480A (en) * 1992-12-17 1995-06-20 Ryder International Corporation Dose dispenser having a molded plastic housing with a cavity and a metallic foil wall covering the cavity
US5631287A (en) * 1994-12-22 1997-05-20 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
JPH09124484A (ja) 1995-10-27 1997-05-13 Schering Purau Kk 点眼剤
JPH10101863A (ja) * 1996-09-30 1998-04-21 Nippon Zeon Co Ltd 成形材料
CA2295512C (en) * 1998-07-14 2009-05-26 Alcon Laboratories, Inc. Prostaglandin product

Also Published As

Publication number Publication date
AU743607B2 (en) 2002-01-31
DE69922916D1 (de) 2005-02-03
EP1011728A1 (de) 2000-06-28
TW585769B (en) 2004-05-01
BR9906597A (pt) 2000-07-18
JP2010100652A (ja) 2010-05-06
JP2002520368A (ja) 2002-07-09
CN1146423C (zh) 2004-04-21
ES2234270T3 (es) 2005-06-16
EP1011728B1 (de) 2004-12-29
AU4822099A (en) 2000-02-07
CA2295512A1 (en) 2000-01-14
AR019773A1 (es) 2002-03-13
PT1011728E (pt) 2005-03-31
CA2295512C (en) 2009-05-26
WO2000003736A1 (en) 2000-01-27
KR20010021835A (ko) 2001-03-15
CN1272063A (zh) 2000-11-01
ZA997794B (en) 2001-01-02
HK1028563A1 (en) 2001-02-23
DE69922916T2 (de) 2005-06-09

Similar Documents

Publication Publication Date Title
DE69922916D1 (de) Polypropylenbasierte behälter für prostaglandin-enthaltende produkte
ATE260593T1 (de) Belüfteter behälter für produkte
DE69811232D1 (de) Behälter für anaerobe produkte
DE69935730D1 (de) Indikator für aerosolcontainer
ATE303953T1 (de) Stapelbare kästen für flaschen niedriger tiefe
DE60036630D1 (de) Behälter für kosmetische produkte
DE69710626D1 (de) Verbesserungen für Behälter
DE69928378D1 (de) Geruchsverstärkende zusammensetzung für kosmetische produkte
ATE343999T1 (de) Behälter für parenterale flüssigkeiten
DK1066073T4 (da) Dispensertrykbeholdere
ITMI941394A0 (it) Etichetta per confezioni richiudibili
DE69926732T2 (de) Abnehmbarer verschluss für kunststoffbehälter
DE69927081D1 (de) Schachtel für Tabakprodukte
DE69508757D1 (de) Verpackungsschale für nahrungsmittel
DE69915291D1 (de) Abgabevorrichtung für fliessfähige Produkte
DE69809441D1 (de) Verpackungsschachtel für nahrungsmitteln
NO20004543L (no) Beholder for jordbruksprodukter
ATE267747T1 (de) Verschluss für behälter flüssiger produkte
DE69635923D1 (de) Schnappverschluss für bierfass
DE69812719D1 (de) Stützrahmen für verpackungsbehälter
DE69600932D1 (de) Schauverpackung für Artikel
DE19780218D2 (de) Verpackung für plattenförmigen Informationsträger
SE9402115D0 (sv) Verpackung für bogenförmige produkte
DK1011728T3 (da) Polypropylenbeholdere til prostaglandinprodukter
DE59909220D1 (de) Overhead-Warenausgabebehälter

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1011728

Country of ref document: EP